Stanford Medicine
Christopher Viehbacher is the Managing Partner of Gurnet Point Capital, a Boston-based investment fund associated with the Bertarelli family, and has a $2 billion capital allocation. He is the former CEO and Member of the Board of Directors of Sanofi and was also the Chairman of the Board of Genzyme in Boston. Prior to joining Sanofi, Chris spent 20 years with GlaxoSmithKline in Germany, Canada, France, and, latterly, the U.S. as President of GSK North America.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Stanford Medicine
Stanford Medicine improves health through leadership, diversity, and collaborative discoveries and innovation in health care, education, and research. The Stanford School of Medicine is a premier setting for integrated research, medical education, and clinical care. As the academic hub of Stanford Medicine, which also comprises adult and pediatric healthcare delivery systems, it fuels discovery and innovation to advance human health while empowering the medical and scientific leaders of tomorrow. Learn more at med.stanford.edu/school.